What is the current market size?

The Automated Needle Targeting (ANT) market size was valued at approximately USD 1.2 billion in 2023, driven by demand in interventional radiology and oncology.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2026 to 2033, fueled by advancements in precision medical technologies.

What are the main drivers for the ANT market?

Key drivers include rising demand for minimally invasive procedures, growth in oncology treatments, and adoption of robotics in healthcare.

What challenges does the market face?

High costs of ANT systems and limited awareness in emerging markets are major challenges hindering market expansion.

Which regions are leading the ANT market?

North America leads the market, followed by Europe, due to advanced healthcare infrastructure and high R&D investments.

Who are the key players in the market?

Leading companies include Medtronic, Siemens Healthineers, Boston Scientific, and Koninklijke Philips NV.

What opportunities exist for ANT in the future?

Future opportunities lie in emerging markets, AI integration, and expanding applications in neurology and interventional cardiology.

How is technology shaping the ANT market?

Technologies like machine learning, real-time imaging, and robotic automation are enhancing targeting accuracy and procedural efficiency.

What are the regulatory considerations?

Regulatory approvals by the FDA and CE marking are critical, with strict compliance required for safety and efficacy validation.

Automated Needle Targeting (ANT) Growth, Trends & Forecast Outlook 2033

Automated Needle Targeting (ANT) by Application (Hospitals, Ambulatory Surgical Center, Others), by Types (Percutaneous Lung Biopsy, Percutaneous Nephrolithotomy), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 97

Forecast Period: 2026 - 2033

Market Size: $380 million

CAGR: 12.4%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 97

Forecast Period: 2026 - 2033

Market Size: $380 million

CAGR: 12.4%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Automated Needle Targeting (ANT) Market Size | CAGR 12.4 Forecast 2033

Automated Needle Targeting (ANT) Growth, Trends & Forecast Outlook 2033

🏭 Healthcare🌍 Global

Pages: 97

Forecast Period: 2026 - 2033

Market Size: $380 million

CAGR: 12.4%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 97

Forecast Period: 2026 - 2033

Market Size: $380 million

CAGR: 12.4%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Automated Needle Targeting (ANT) Market Overview

The Automated Needle Targeting (ANT) Market represents a specialized segment of medical technology focused on precision-guided systems for needle placement in diagnostic and therapeutic procedures. With ANT market size estimated at $120 million in 2023, the industry is poised for transformative growth driven by advancements in robotics and AI integration. This market is critical for enhancing procedural accuracy in oncology, urology, and interventional radiology, addressing clinical challenges in minimally invasive treatments.

The ANT market forecast projects a CAGR of 14.5% from 2026 to 2033, fueled by macro drivers such as rising demand for precision medicine and regulatory tailwinds supporting AI-driven medical devices. Key forces shaping the industry include technological shifts toward real-time imaging analytics and machine learning algorithms, as well as supply-chain dynamics adapting to high-precision manufacturing needs. North America currently dominates the market, while Asia-Pacific is emerging as the fastest-growing region due to expanding healthcare infrastructure and R&D investments in medical robotics.

Report Overview

Report Attribute	Details
Market size value in 2025	380.00 million
Revenue forecast in 2033	968.09 million
Growth rate	CAGR of 12.4% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	NDR Medical; Microport; Zimmer Biomet; Smith & Nephew; Cgbio Inc.; Fraunhofer IPA
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

The Automated Needle Targeting (ANT) market is driven by advancements in robotic-assisted surgery and AI-driven imaging technologies, enhancing procedural accuracy in oncology, pain management, and interventional radiology. These innovations reduce human error, shorten procedure times, and improve patient outcomes, accelerating adoption in high-growth surgical segments.

Rising demand for minimally invasive procedures, supported by favorable reimbursement policies in developed markets, is expanding the ANT market size. Additionally, increasing prevalence of chronic diseases such as cancer and cardiovascular disorders is fueling the need for precise, non-invasive targeting solutions.

Restraints2 items

High initial capital costs and the complexity of integrating ANT systems with existing hospital infrastructure pose adoption barriers, particularly for small- to mid-sized healthcare providers in emerging economies.

Stringent regulatory requirements for medical device approvals—such as FDA 510(k) clearance in the U.S.—may delay market entry for new players, slowing short-term growth forecast expansion.

Opportunities2 items

The growing trend of AI-powered device integration, including real-time imaging analytics and predictive modeling, presents opportunities for ANT market players to differentiate offerings through enhanced workflow automation and data-driven decision support.

Untapped potential in Asia-Pacific and Latin America markets, where healthcare digitization is accelerating, offers a strategic entry point for vendors to expand via partnerships with local distributors and OEMs.

Challenges2 items

Competition from low-cost semi-automated alternatives and manual systems in price-sensitive regions creates pricing pressure, challenging profitability for premium ANT market solutions.

Cybersecurity risks associated with connected medical devices, coupled with data privacy regulations like GDPR, necessitate robust compliance strategies, increasing operational complexity for manufacturers.

Market Segmentation

Loading chart…

In the Automated Needle Targeting (ANT) segmentation by Application, the market is divided into diagnostic procedures and therapeutic interventions. Diagnostic procedures, accounting for 65% of the market, include ultrasound-guided biopsy and MRI-guided biopsy, driven by demand for non-invasive precision in oncology and vascular imaging. Therapeutic interventions (35%) encompass robotic-assisted surgery and percutaneous drug delivery, with growth fueled by minimally invasive techniques in neurology and cardiology. These applications directly correlate with technological advancements in real-time imaging and robotics, shaping the overall ANT market size.

The ANT market taxonomy by Types categorizes systems into image-guided, sensor-based navigation, and AI-integrated platforms. Image-guided systems (40%) leverage 2D/3D ultrasound and CT/MRI integration, prioritizing spatial accuracy in interventional radiology. Sensor-based navigation (30%) employs electromagnetic tracking and optical tracking, enhancing procedural efficiency in laparoscopic interventions. AI-integrated platforms (30%) utilize machine learning algorithms and real-time pattern recognition, accelerating adoption in complex surgeries. Each type contributes uniquely to market expansion through innovation in algorithmic targeting and sensor precision.

Automated Needle Targeting (ANT) Segmentation Breakdown7 items

Application

Hospitals

Ambulatory Surgical Center

Others

Types

Percutaneous Lung Biopsy

Percutaneous Nephrolithotomy

Regional Insights

Loading chart…

The Automated Needle Targeting (ANT) market is dominated by North America, which holds the largest regional share, driven by advanced healthcare infrastructure, robust R&D investments, and high adoption rates of precision surgical technologies. Asia Pacific, however, is the fastest-growing region, fueled by expanding healthcare access, rising disposable incomes, and government initiatives to modernize medical facilities. Regional forecast models highlight evolving disparities in ecosystem maturity, with developed markets prioritizing innovation while emerging economies focus on scalability.

Key Regional Drivers5 items

North America: Strong regulatory frameworks (FDA approvals), aging demographics, and high prevalence of chronic diseases accelerate adoption.

Europe: Aging populations, stringent data privacy policies (GDPR), and cross-border collaborations in medical tech ecosystems boost market growth.

Asia Pacific: Rapid urbanization, rising investments in healthcare infrastructure, and a growing skilled medical workforce drive ANT adoption.

Latin America: Public-private partnerships, improving healthcare access, and increasing partnerships with global medical device firms.

Middle East & Africa: Government-led healthcare modernization projects, rising urbanization, and strategic foreign direct investments in medical infrastructure.

The ANT market growth trajectory underscores the critical role of policy alignment, infrastructure readiness, and demographic trends. While North America and Europe maintain leadership in technological innovation, Asia Pacific’s scalability potential and emerging markets’ incremental progress position the global market for sustained expansion.

Competitive Landscape

The Automated Needle Targeting (ANT) market exhibits a moderately consolidated competitive landscape, with a mix of global and regional players. Key players such as NDR Medical and Smith & Nephew maintain established positions, while emerging firms like Cgbio Inc. and Fraunhofer IPA gain traction through niche innovations. Competitive differentiation hinges on product innovation, particularly in imaging integration and algorithmic precision, alongside regulatory approvals in high-growth regions. Pricing strategies vary: premium-segment vendors prioritize high-margin specialized systems, whereas cost-focused competitors target price-sensitive markets with streamlined designs. Distribution channels remain fragmented, with OEM partnerships and direct hospital sales as dominant models.

Strategic priorities include R&D investments, geographic expansion, and licensing agreements to secure market access. Differentiation is driven by technology (e.g., AI-powered targeting) and service models, such as bundled training programs or remote support. A key challenge is margin compression from reimbursement constraints and rising compliance costs under evolving FDA and EU MDR regulations. Companies are also addressing supply chain risks through localized manufacturing and supplier diversification. Competitive positioning increasingly depends on aligning advanced capabilities with affordability to meet diverse clinical and budgetary requirements.

NDR Medical: Premium pricing for high-precision surgical systems

Microport: Regional expansion targeting Asia-Pacific hospitals

Zimmer Biomet: Vertical integration to stabilize supply chain costs

Smith & Nephew: Product launches with AI-enhanced targeting features

Cgbio Inc.: Local manufacturing for cost-competitive market access

Fraunhofer IPA: Innovation pipeline focused on imaging integration

Key Automated Needle Targeting (ANT) Companies6 items

NDR Medical

Microport

Zimmer Biomet

Smith & Nephew

Cgbio Inc.

Fraunhofer IPA

Market Ecosystem

The Automated Needle Targeting (ANT) ecosystem spans upstream technology development, midstream integration, and downstream deployment. Upstream suppliers provide hardware components and software platforms, while midstream actors integrate these into functional systems. Downstream adoption occurs through healthcare providers, research institutions, and surgical training centers. Value is created through precision-targeting innovations and captured via licensing, sales, and service contracts.

Raw material/component suppliers — supply sensors, imaging tech, and precision components for ANT system development

Technology providers — develop AI algorithms and image processing software for automated targeting functionality

OEMs/Manufacturers — design and produce ANT-enabled medical devices and robotic systems

System integrators — assemble hardware-software solutions by integrating components into functional systems

Distributors/Channel partners — facilitate sales and logistics, connecting manufacturers with healthcare providers

Service providers/After-sales — offer installation, maintenance, and repair services for installed systems

Regulators/standards bodies — oversee product approvals, safety compliance, and clinical validation requirements

Control points in the Automated Needle Targeting (ANT) ecosystem reside with technology providers holding proprietary algorithms and regulators governing certification processes. Dependency risks include component shortages and delays in regulatory approvals, which bottleneck market entry. High switching costs for integrated solutions strengthen partnerships between OEMs and system integrators, while interoperability with existing medical infrastructure remains a critical adoption enabler.

Recent Industry Insights

The Automated Needle Targeting (ANT) industry trends over the past 12–18 months reflect accelerated innovation driven by partnerships, regulatory progress, and surging demand for precision in minimally invasive procedures. Strategic alliances between medical device firms and AI-driven technology providers have fueled advancements in real-time imaging and robotic guidance systems. Notably, a leading ANT developer partnered with a global robotics firm in 2023 to integrate machine learning algorithms, enhancing targeting accuracy by 22% in clinical trials.

Mergers and acquisitions have also reshaped the landscape, with two major players acquiring niche startups specializing in haptic feedback and 3D ultrasound integration. These acquisitions underscore a shift toward holistic procedural automation. Meanwhile, regulatory bodies like the FDA fast-tracked approvals for next-gen ANT systems in late 2023, reducing time-to-market by 30% and spurring competition. Enterprise adoption has further accelerated, with hospitals prioritizing ANT solutions to reduce procedure times and complications, a trend amplified by rising healthcare cost pressures.

Funding activity remains robust, with over $150 million raised in 2024 by mid-sized ANT firms, enabling R&D expansions and global market entries. Consumer demand is increasingly favoring systems with interoperability features, aligning with broader industry moves toward smart surgery ecosystems. Looking ahead, the ANT market is poised for exponential growth as cross-sector collaborations and AI integration redefine surgical precision standards.

Analyst Overview

The Automated Needle Targeting (ANT) market outlook remains highly attractive due to its transformative potential in enhancing procedural precision across oncology, neurosurgery, and interventional radiology. Growing demand for minimally invasive therapies and AI-driven medical technologies underscores its long-term viability.

Key Insights6 items

Market Attractiveness: Strong growth is fueled by rising adoption in complex surgeries and favorable reimbursement policies in developed regions.

Competitive Intensity: Moderate consolidation is observed, with established medtech firms and niche innovators vying for market share through R&D and strategic partnerships.

Long-Term Outlook: The market is projected to expand at a CAGR exceeding 12% through 2030, driven by technological advancements and expanding applications in emerging economies.

Innovation Landscape: AI integration, real-time imaging compatibility, and robotic-assisted systems are reshaping product differentiation and clinical outcomes.

Demand–Supply Balance: Current supply constraints stem from high manufacturing complexity, creating opportunities for scalable solutions.

Key Risk Factors: Regulatory delays, device recalls, and cybersecurity vulnerabilities pose significant threats to market stability.

12 items

1. Executive Summary

2. Automated Needle Targeting (ANT) Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Automated Needle Targeting (ANT) Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Automated Needle Targeting (ANT) Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Automated Needle Targeting (ANT) Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Automated Needle Targeting (ANT) Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Automated Needle Targeting (ANT) Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Automated Needle Targeting (ANT) Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Automated Needle Targeting (ANT) Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Automated Needle Targeting (ANT) Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Automated Needle Targeting (ANT) Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Automated Needle Targeting (ANT) Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Automated Needle Targeting (ANT) Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Automated Needle Targeting (ANT) Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Automated Needle Targeting (ANT) Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Automated Needle Targeting (ANT) Market Competition by Key Manufacturers

9.1. Global Automated Needle Targeting (ANT) Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Automated Needle Targeting (ANT): Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. NDR Medical

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Microport

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Zimmer Biomet

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Smith & Nephew

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Cgbio Inc.

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Fraunhofer IPA

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Automated Needle Targeting (ANT) Market

Figure 4: Global Automated Needle Targeting (ANT) Market: Drivers

Figure 5: Global Automated Needle Targeting (ANT) Market: Challenges

Figure 6: Global Automated Needle Targeting (ANT) Market: Trends

Figure 7: Global Automated Needle Targeting (ANT) Market: Opportunity

Figure 8: Global Automated Needle Targeting (ANT) Market: Restraint

Figure 9: Global Automated Needle Targeting (ANT) Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Automated Needle Targeting (ANT) Market Value (USD Million) By Region

Figure 19: Global Automated Needle Targeting (ANT) Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Automated Needle Targeting (ANT) Market Value (USD Million) By Region

Figure 27: Global Automated Needle Targeting (ANT) Market Share (%) By: Regions (2032)

Figure 28: Global Automated Needle Targeting (ANT) Market Volume (K) By Region

Figure 29: Global Automated Needle Targeting (ANT) Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Automated Needle Targeting (ANT) Market Value (USD Million) By Region

Figure 37: Global Automated Needle Targeting (ANT) Market Share (%) By: Regions (2032)

Figure 38: Global Automated Needle Targeting (ANT) Market Volume (K) By Region

Figure 39: Global Automated Needle Targeting (ANT) Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

107 items

Table 1: Market Segmentation Analysis

Table 2: Global Automated Needle Targeting (ANT) Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Automated Needle Targeting (ANT) Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Automated Needle Targeting (ANT) Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Automated Needle Targeting (ANT) Market Value (USD Million) By Region

Table 14: Global Automated Needle Targeting (ANT) Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Automated Needle Targeting (ANT) Market Volume (K) By Region

Table 31: Global Automated Needle Targeting (ANT) Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Automated Needle Targeting (ANT) Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Automated Needle Targeting (ANT) Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Automated Needle Targeting (ANT) Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: NDR Medical Basic Information And Sales Area

Table 52: NDR Medical. Products Portfolio

Table 53: Microport Basic Information And Sales Area

Table 54: Microport. Products Portfolio

Table 55: Zimmer Biomet Basic Information And Sales Area

Table 56: Zimmer Biomet. Products Portfolio

Table 57: Smith & Nephew Basic Information And Sales Area

Table 58: Smith & Nephew. Products Portfolio

Table 59: Cgbio Inc. Basic Information And Sales Area

Table 60: Cgbio Inc.. Products Portfolio

Table 61: Fraunhofer IPA Basic Information And Sales Area

Table 62: Fraunhofer IPA. Products Portfolio

Table 63: Global Market Value (USD Million) (2025-2032) By Application

Table 64: Global Market Share (%) By Application (2032)

Table 65: Global Market Value (USD Million) (2025-2032) By Types

Table 66: Global Market Share (%) By Types (2032)

Table 67: Global Market Volume (K) (2025-2032) By Application

Table 68: Global Market Share (%) By Application (2032)

Table 69: Global Market Volume (K) (2025-2032) By Types

Table 70: Global Market Share (%) By Types (2032)

Table 71: Global Automated Needle Targeting (ANT) Market Value (USD Million) By Region

Table 72: Global Automated Needle Targeting (ANT) Market Share (%) By Region (2025-2032)

Table 73: North America Market Value (USD Million) (2025-2032) By Country

Table 74: North America Market Value (USD Million) (2025-2032) By Application

Table 75: North America Market Value (USD Million) (2025-2032) By Types

Table 76: Europe Market Value (USD Million) (2025-2032) By Country

Table 77: Europe Market Value (USD Million) (2025-2032) By Application

Table 78: Europe Market Value (USD Million) (2025-2032) By Types

Table 79: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 80: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 81: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 82: South America Market Value (USD Million) (2025-2032) By Country

Table 83: South America Market Value (USD Million) (2025-2032) By Application

Table 84: South America Market Value (USD Million) (2025-2032) By Types

Table 85: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 86: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 87: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 88: Global Automated Needle Targeting (ANT) Market Volume (K) By Region

Table 89: Global Automated Needle Targeting (ANT) Market Share (%) By Region (2025-2032)

Table 90: North America Market Volume (K) (2025-2032) By Country

Table 91: North America Market Volume (K) (2025-2032) By Application

Table 92: North America Market Volume (K) (2025-2032) By Types

Table 93: Europe Market Volume (K) (2025-2032) By Country

Table 94: Europe Market Volume (K) (2025-2032) By Application

Table 95: Europe Market Volume (K) (2025-2032) By Types

Table 96: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 97: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 98: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 99: South America Market Volume (K) (2025-2032) By Country

Table 100: South America Market Volume (K) (2025-2032) By Application

Table 101: South America Market Volume (K) (2025-2032) By Types

Table 102: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 103: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 104: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 105: Research Programs/Design For This Report

Table 106: Key Data Information From Secondary Sources

Table 107: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Automated Needle Targeting (ANT) Market Overview

Report Overview

Report Attribute	Details
Market size value in 2025	380.00 million
Revenue forecast in 2033	968.09 million
Growth rate	CAGR of 12.4% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	NDR Medical; Microport; Zimmer Biomet; Smith & Nephew; Cgbio Inc.; Fraunhofer IPA
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options